Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Aug-08 4:50 PM View:  | Campbell Robert E Director | Barrier Therapeutics Inc. (BTRX) | 06-Aug-08 | Disposition (change in control) | 3,273 | $4.15 | $13,583.00 | (100%) 3.27K to 0 | < 1% |
| 08-Aug-08 4:33 PM View: | Jp Morgan Partners Bhca Lp 10% Owner | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 651,125 | $4.15 | $2,702,170.00 | (100%) 651.13K to 0 | < 1% |
| 05-Aug-08 10:00 PM View: | Stiefel Laboratories, Inc. 10% Owner | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Market Purchase | 34,266,500 | $4.15 | $142,206,000.00 | 100% 0 to 34.27M | (< 1%) |
| 06-Aug-08 5:10 PM View: | Reilly Dennis Chief Financial Officer | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 20,313 | $4.15 | $84,299.00 | (100%) 20.31K to 0 | < 1% |
| 08-Aug-08 4:31 PM View: | Akkaraju Srinivas Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 2,656,840 | $4.15 | $11,025,900.00 | (100%) 2.66M to 0 | < 1% |
| 06-Aug-08 4:49 PM View: | Jacey Charles F Jr Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 600 | $4.15 | $2,490.00 | (100%) 0.6K to 0 | < 1% |
| 06-Aug-08 4:50 PM View: | Altomari Alfred Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 62,106 | $4.15 | $257,740.00 | (100%) 62.11K to 0 | < 1% |
| 06-Aug-08 4:48 PM View: | Erickson Edward L Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 2,000 | $4.15 | $8,300.00 | (100%) 2.0K to 0 | < 1% |
| 08-Aug-08 4:33 PM View: | Jp Morgan Partners Bhca Lp 10% Owner | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 2,005,720 | $4.15 | $8,323,720.00 | (75%) 2.66M to 651.13K | < 1% |
| 06-Aug-08 5:04 PM View: | Shroot Braham Chief Scientific Officer | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 12,500 | $4.15 | $51,875.00 | (100%) 12.5K to 0 | < 1% |
| 06-Aug-08 4:50 PM View: | Campbell Robert E Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 6,000 | $4.15 | $24,900.00 | (65%) 9.27K to 3.27K | < 1% |
| 06-Aug-08 4:49 PM View: | Ehmann Carl Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 1,979 | $4.15 | $8,212.85 | (100%) 1.98K to 0 | < 1% |
| 06-Aug-08 4:52 PM View: | Cauwenbergh Geert Director | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 635,613 | $4.15 | $2,637,790.00 | (100%) 635.61K to 0 | < 1% |
| 06-Aug-08 5:02 PM View: | Bristow Albert General Counsel & Corp Sec'y 10% Owner | Barrier Therapeutics Inc. (BTRX) | 05-Aug-08 | Disposition (change in control) | 23,132 | $4.15 | $95,997.80 | (100%) 23.13K to 0 | < 1% |
| 07-Apr-08 11:14 AM View: | Bristow Albert General Counsel & Corp Sec'y | Barrier Therapeutics Inc. (BTRX) | 03-Apr-08 | Payment of Exercise | 315 | $3.44 | $1,083.60 | (1%) 23.45K to 23.13K | 32% |
| 07-Apr-08 11:13 AM View: | Cauwenbergh Geert Director | Barrier Therapeutics Inc. (BTRX) | 03-Apr-08 | Payment of Exercise | 1,724 | $3.44 | $5,930.56 | (< 1%) 637.34K to 635.61K | 32% |
| 17-Mar-08 4:35 PM View: | Bristow Albert General Counsel & Corp Sec'y | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 5,833 | $3.35 | $19,540.50 | 32% 18.18K to 24.01K | (30%) |
| 17-Mar-08 4:35 PM View: | Altomari Alfred Chief Operating Officer Director | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 16,667 | $3.35 | $55,834.40 | 38% 43.94K to 60.61K | (30%) |
| 17-Mar-08 4:34 PM View: | Vanlent Anne Exec VP & CFO | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 10,000 | $3.35 | $33,500.00 | 7% 138.85K to 148.85K | (30%) |
| 17-Mar-08 4:35 PM View: | Shroot Braham Chief Scientific Officer | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 12,500 | $3.35 | $41,875.00 | 100% 0 to 12.5K | (30%) |
| 17-Mar-08 4:35 PM View: | Bristow Albert General Counsel & Corp Sec'y | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Payment of Exercise | 563 | $3.35 | $1,886.05 | (2%) 24.01K to 23.45K | 30% |
| 17-Mar-08 4:34 PM View: | Reilly Dennis VP Finance & PAO | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 4,167 | $3.35 | $13,959.40 | 28% 14.65K to 18.81K | (30%) |
| 17-Mar-08 4:36 PM View: | Cauwenbergh Geert Chief Executive Officer | Barrier Therapeutics Inc. (BTRX) | 14-Mar-08 | Grant | 28,333 | $3.35 | $94,915.50 | 5% 609.0K to 637.34K | (30%) |
| 07-Mar-08 3:26 PM View: | Cauwenbergh Geert Chief Executive Officer | Barrier Therapeutics Inc. (BTRX) | 07-Mar-08 | Grant | 1,000 | $3.17 | $3,170.00 | < 1% 608.0K to 609.0K | (26%) |
| 04-Mar-08 3:37 PM View: | Cauwenbergh Geert Chief Executive Officer | Barrier Therapeutics Inc. (BTRX) | 04-Mar-08 | Grant | 1,500 | $3.42 | $5,130.00 | < 1% 606.5K to 608.0K | (30%) |
| 07-Dec-07 3:30 PM View: | Reilly Dennis VP Finance & PAO | Barrier Therapeutics Inc. (BTRX) | 06-Dec-07 | Payment of Exercise | 88 | $4.10 | $360.80 | (< 1%) 13.23K to 13.15K | 42% |
| 07-Dec-07 3:29 PM View: | Bristow Albert General Counsel & Corp Sec'y | Barrier Therapeutics Inc. (BTRX) | 06-Dec-07 | Payment of Exercise | 689 | $4.10 | $2,824.90 | (4%) 18.87K to 18.18K | 42% |
| 04-Apr-07 5:01 PM View: | Nomides Charles Chief R&D Officer | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 8,333 | $6.87 | $57,247.70 | 10% 82.5K to 90.83K | (65%) |
| 04-Apr-07 5:01 PM View: | Reilly Dennis VP Finance & PAO | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 2,085 | $6.87 | $14,324.00 | 22% 9.65K to 11.73K | (65%) |
| 04-Apr-07 5:01 PM View: | Bristow Albert General Counsel & Corp Sec'y | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 4,417 | $6.87 | $30,344.80 | 31% 14.18K to 18.6K | (65%) |
| 04-Apr-07 5:02 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 21,000 | $6.87 | $144,270.00 | 4% 585.5K to 606.5K | (65%) |
| 04-Apr-07 5:02 PM View: | Altomari Alfred Chief Operating Officer | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 15,000 | $6.87 | $103,050.00 | 57% 26.16K to 41.16K | (65%) |
| 04-Apr-07 5:04 PM View: | Vanlent Anne Exec VP & CFO | Barrier Therapeutics Inc. (BTRX) | 03-Apr-07 | Grant | 6,667 | $6.87 | $45,802.30 | 5% 133.63K to 140.3K | (65%) |
| 08-Dec-06 8:00 PM View: | Bristow Albert General Counsel and Secretary | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 13,083 | $7.43 | $97,206.70 | 1114% 1.17K to 14.26K | (68%) |
| 08-Dec-06 8:01 PM View: | Reilly Dennis VP, Finance & PAO | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 1,667 | $7.43 | $12,385.80 | 111% 1.5K to 3.17K | (68%) |
| 08-Dec-06 8:03 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 54,167 | $7.43 | $402,461.00 | 10% 518.87K to 573.03K | (68%) |
| 08-Dec-06 8:03 PM View: | Altomari Alfred Chief Operating Officer | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 22,083 | $7.43 | $164,077.00 | 779% 2.83K to 24.92K | (68%) |
| 08-Dec-06 8:02 PM View: | Vanlent Anne Exec V.P., CFO and Treasurer | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 15,833 | $7.43 | $117,639.00 | 14% 113.91K to 129.74K | (68%) |
| 08-Dec-06 8:01 PM View: | Nomides Charles Chief R&D Officer | Barrier Therapeutics Inc. (BTRX) | 06-Dec-06 | Grant | 7,500 | $7.43 | $55,725.00 | 10% 75.0K to 82.5K | (68%) |
| 14-Nov-06 11:15 AM View: | Erickson Edward L Director | Barrier Therapeutics Inc. (BTRX) | 13-Nov-06 | Market Purchase | 2,000 | $7.22 | $14,439.00 | 100% 0 to 2.0K | (67%) |
| 11-Apr-07 9:49 AM View: | Ehmann Carl Director | Barrier Therapeutics Inc. (BTRX) | 07-Nov-06 | Disposition | 21 | $6.49 | $136.37 | (1%) 2.0K to 1.98K | 63% |
| 27-Sep-06 4:06 PM View: | Jacey Charles F Jr Director | Barrier Therapeutics Inc. (BTRX) | 27-Sep-06 | Market Purchase | 300 | $6.40 | $1,920.00 | 100% 0.3K to 0.6K | (63%) |
| 10-Aug-06 2:36 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 09-Aug-06 | Market Purchase | 1,000 | $5.43 | $5,430.20 | < 1% 527.87K to 528.87K | (56%) |
| 10-Aug-06 2:36 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 09-Aug-06 | Market Purchase | 1,000 | $5.44 | $5,437.00 | < 1% 528.87K to 529.87K | (56%) |
| 16-Jun-06 1:16 PM View: | Campbell Robert E Director | Barrier Therapeutics Inc. (BTRX) | 16-Jun-06 | Market Purchase | 3,000 | $5.92 | $17,751.00 | 100% 3.0K to 6.0K | (59%) |
| 19-May-06 11:22 AM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 19-May-06 | Market Purchase | 4,000 | $6.17 | $24,680.00 | < 1% 522.56K to 526.56K | (61%) |
| 19-May-06 11:22 AM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 19-May-06 | Market Purchase | 1,000 | $6.17 | $6,166.00 | < 1% 521.56K to 522.56K | (61%) |
| 15-Mar-06 1:36 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 15-Mar-06 | Market Purchase | 2,000 | $9.25 | $18,496.80 | < 1% 519.56K to 521.56K | (74%) |
| 06-Mar-06 3:14 PM View: | Campbell Robert E Director | Barrier Therapeutics Inc. (BTRX) | 06-Mar-06 | Market Purchase | 1,000 | $9.97 | $9,970.00 | 50% 2.0K to 3.0K | (76%) |
| 14-Mar-05 1:37 PM View: | Cauwenbergh Geert Chief Executive Officer Director | Barrier Therapeutics Inc. (BTRX) | 11-Mar-05 | Option Exercise | 2,970 | $3.50 | $10,395.00 | < 1% 511.32K to 514.29K |
